Home Latest news Therapy for junctional epidermolysis bullosa

Therapy for junctional epidermolysis bullosa

by admin
778 views

The journal Nature has published an article about junctional epidermolysis bullosa (JEB). JEB is a severe and often lethal genetic disease caused by mutations in genes encoding the basement membrane component laminin-332. Surviving patients with JEB develop chronic wounds to the skin and mucosa, which impair their quality of life and lead to skin cancer. In this article the authors show that autologous transgenic keratinocyte cultures regenerated an entire, fully functional epidermis on a seven-year-old child suffering from a devastating, life-threatening form of JEB. The full-text article you can read here.

Related Articles